Physician profile
David W Vanhooser
NPI 1649279779
$25,086.89
in general payments reported to CMS, 2019-2025
29 companies · $737 in 2025
The $737 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,600 · 2020: $11K · 2021: $348 · 2022: $2,626 · 2023: $2,161 · 2024: $3,272 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,234 · Travel and Lodging: $1,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,233.60 |
| Travel and Lodging | $1,937.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,790.77 | 2019-2022 | |
| Abiomed | $4,804.82 | 2019-2025 | Impella |
| Abbott Laboratories | $3,780.21 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet, Mitraclip |
| Medtronic, INC. | $1,339.33 | 2021-2025 | Corevalve Evolut R, Endurant Iis, Penditure |
| Atricure, INC. | $1,144.39 | 2019-2024 | |
| Medical Device Business Services, INC. | $971.79 | 2019 | |
| Medtronic Vascular, INC. | $762.38 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $428.27 | 2019-2022 | |
| Paragonix Technologies, INC. | $162.48 | 2022 | |
| Inari Medical, INC. | $162.04 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $72.80 | 2024 | Torus Stent Graft System, Endocross Device |
| Depuy Synthes Sales INC. | $65.74 | 2022-2025 | |
| Biom'Up France Sas | $60.07 | 2020 | |
| Ethicon US, LLC | $59.20 | 2019-2020 | |
| Silk Road Medical, INC. | $57.72 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $51.61 | 2019-2024 | Kengreal, Cleviprex |
| Getinge USA Sales, LLC | $48.09 | 2020 | |
| Edwards Lifesciences Corporation | $39.82 | 2020-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.29 | 2025 | Lifevest |
| Avanos Medical | $38.61 | 2019 | |
| Angiodynamics, INC. | $35.58 | 2019-2022 | |
| Corcym INC | $33.72 | 2023 | Perceval |
| Merck Sharp & Dohme LLC | $23.93 | 2023 | Bridion |
| Reflow Medical INC | $22.55 | 2025 | |
| Cvrx, INC. | $20.39 | 2025 | Barostim Neo System |
| Solventum Corporation | $20.25 | 2025 | Activ.A.C. |
| Medtronic USA, INC. | $18.89 | 2020 | |
| Surmodics, INC. | $18.88 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Biomerieux INC | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Vanhooser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.